⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23528137 | 0.00 | — | — | |
| Methane SCHEMBL23088734 | 0.00 | — | — | |
| SCHEMBL25435790 | 0.00 | — | — | |
| SCHEMBL23358113 | 0.00 | — | — | |
| Potassium Ion SCHEMBL23462035 | 0.00 | CA4 (0.50) | — | |
| Potassium Ion SCHEMBL23462163 | 0.00 | CA4 (0.50) | — | |
| Hydrogen Sulfide SCHEMBL23805181 | 0.00 | — | — | |
| SCHEMBL25434707 | 0.00 | — | — | |
| SCHEMBL25435013 | 0.00 | — | — | |
| SCHEMBL23466331 | 0.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021195163-A1 | OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR | OCULAR THERAPEUTIX, INC. (US) | 2021-09-30 | — | — | WO | disclosed |
| WO-2021158968-A1 | COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES | OCULAR THERAPEUTIX, INC. (US) | 2021-08-12 | — | — | WO | disclosed |
| EP-3621975-A1 | COMPOUNDS FOR THE TREATMENT OF SYSTEMIC INSULIN RESISTANCE DISORDERS AND THE USE THEREOF | Galectin Sciences, LLC (US) | 2020-03-18 | — | — | EP | disclosed |
| EP-3615701-A2 | SHAPE MEMORY ARTICLES AND METHODS FOR CONTROLLING PROPERTIES | Medtronic Inc. (US) | 2020-03-04 | — | — | EP | disclosed |
| EP-3549099-A1 | AUTOMATED DETECTION AND REPOSITIONING OF MICRO-OBJECTS IN MICROFLUIDIC DEVICES | Berkeley Lights, Inc. (US) | 2019-10-09 | — | — | EP | disclosed |
| WO-2018209276-A1 | COMPOUNDS FOR THE TREATMENT OF SYSTEMIC INSULIN RESISTANCE DISORDERS AND THE USE THEREOF | GALECTIN SCIENCES, LLC (US) | 2018-11-15 | — | — | WO | disclosed |
| WO-2018201111-A2 | SHAPE MEMORY ARTICLES AND METHODS FOR CONTROLLING PROPERTIES | MEDTRONIC INC. (US) | 2018-11-01 | — | — | WO | disclosed |
| EP-3078195-A1 | VIDEO ENCODING AND DECODING | Nokia Technologies OY (FI) | 2016-10-12 | — | — | EP | disclosed |
| EP-3050162-A1 | POWER TERMINAL CONNECTOR | Tyco Electronics Corporation (US) | 2016-08-03 | — | — | EP | disclosed |
| EP-3046560-A1 | STEM CELL MODULATION II | University of Canberra (AU) | 2016-07-27 | — | — | EP | disclosed |
| WO-2015184130-A1 | VACCINES FOR CONTROL OF EPIDEMIC AEROMONAS HYDROPHILA GENERATED BY MARKERLESS GENE DELETION | AUBURN UNIVERSITY (US) | 2015-12-03 | — | — | WO | disclosed |
| WO-2015039187-A1 | STEM CELL MODULATION II | UNIVERSITY OF CANBERRA (AU) | 2015-03-26 | — | — | WO | disclosed |
| EP-2560684-A1 | FIBRONECTIN TYPE III DOMAIN-BASED MULTIMERIC SCAFFOLDS | MedImmune, LLC (US) | 2013-02-27 | — | — | EP | disclosed |
| EP-2411352-A2 | ANTIVIRAL COMPOUNDS AND USES THEREOF | Abbott Laboratories (US) | 2012-02-01 | — | — | EP | disclosed |
| WO-2011130324-A1 | FIBRONECTIN TYPE III DOMAIN-BASED MULTIMERIC SCAFFOLDS | MEDIMMUNE, LLC (US) | 2011-10-20 | — | — | WO | disclosed |
| EP-2265590-A2 | SELECTIVE INHIBITORS OF HISTONE DEACETYLASE | PHARMACYCLICS, INC. (US) | 2010-12-29 | — | — | EP | disclosed |
| WO-2010111436-A2 | ANTIVIRAL COMPOUNDS AND USES THEREOF | ABBOTT LABORATORIES (US) | 2010-09-30 | — | — | WO | disclosed |
| EP-2232859-A2 | APPARATUS FOR TRANSMITTING AND RECEIVING A SIGNAL AND METHOD OF TRANSMITTING AND RECEIVING A SIGNAL | LG Electronics Inc. (KR) | 2010-09-29 | — | — | EP | disclosed |
| WO-2009129335-A2 | SELECTIVE INHIBITORS OF HISTONE DEACETYLASE | PHARMACYCLICS, INC. (US) | 2009-10-22 | — | — | WO | disclosed |
| WO-2009075538-A2 | APPARATUS FOR TRANSMITTING AND RECEIVING A SIGNAL AND METHOD OF TRANSMITTING AND RECEIVING A SIGNAL | LG ELECTRONICS INC. (KR) | 2009-06-18 | — | — | WO | disclosed |